This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Howard Bauchner, MD
818 Harrison Ave Boston, MA 02118

Arch Pediatr Adolesc Med. 1996;150(12):1315.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I believe that amoxicillin continues to be the drug of choice for therapy for acute otitis media. Ceftriaxone may be an alternative for selected patients. The following points are important in response to Dr Semones' comments:

1. Ceftriaxone is not currently approved by the Food and Drug Administration for treatment of acute otitis media.
   
2. If and when it is approved, its use should be considered for specific clinical circumstances, such as acute otitis media in a young infant who may also have bacteremia.
   
3. Selective use of oral antibiotics for all indications should be fostered.
   
4. We are unaware of any data that indicate that a single dose of ceftriaxone is more likely to foster development of resistant pathogens than a 10-day course of an oral antibiotic approved for therapy for acute otitis media.
   

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?